🇺🇸 FDA

Intelligence · INN Directory

Pharmaceutical Drugs

Regulatory status, brand names, and pipeline context for BD, medical affairs, and competitive intelligence teams.

Drugs indexed
4,797
Companies
1,769
Pipeline programs
20,548

Quick answer

NovaPharmaNews tracks 4,797 pharmaceutical drugs by INN (International Nonproprietary Name), with US FDA approval status, brand names, originators, routes of administration, and links to pipeline programs and patents. Search by generic name or browse A–Z for competitive intelligence and medical affairs reference.

11 results for “Adalimumab” Clear

  1. adalimumab

    ABRILADA Pfizer Australia Pty Ltd

    approved

    L04AB04

  2. adalimumab-aacf

    IDACIO

    SUBCUTANEOUS approved

  3. adalimumab-aaty

    YUFLYMA

    INJECTION approved

  4. adalimumab-adaz

    HYRIMOZ

    INJECTION approved

  5. adalimumab-adbm

    CYLTEZO

    INJECTION approved

  6. adalimumab-afzb

    ABRILADA

    INJECTION approved

  7. adalimumab-aqvh

    YUSIMRY Coherus Oncology

    INJECTION approved

  8. adalimumab-atto

    AMJEVITA

    INJECTION approved

  9. adalimumab-bwwd

    HADLIMA

    INJECTION approved

  10. adalimumab-fkjp

    HULIO

    INJECTION approved

  11. adalimumab-ryvk

    SIMLANDI

    INJECTION approved

Frequently asked questions

What is the NovaPharmaNews drugs directory?

It is a searchable index of 4,797 pharmaceutical active ingredients and their marketed profiles — INN, brand names, US regulatory status, manufacturers, and cross-links to clinical pipeline and patent records.

Where does drug approval data come from?

Profiles combine FDA Drugs@FDA and Orange Book references, ClinicalTrials.gov pipeline links, and editorial enrichment. See our data sources page for attribution and update cadence. This directory is for professional reference, not medical advice.

How do I find a drug by brand name?

Use the search box on this page — it matches both INN (generic name) and slug. Brand names appear on each drug row and on the full drug profile page, with links to the originator company when available.

Data attribution and licensing: Data sources